USP12 promotes antiviral responses by deubiquitinating and stabilizing IFI16
PLOS Pathogens · 2023
DOI: 10.1371/journal.ppat.1011480 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, 2023. Verfasst von Yuling Fu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biotherapy, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Herpesvirus 1, Human, Herpes Simplex. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Basic and Applied Basic Research Foundation of Guangdong Province.
Abstract (Originalsprache)
Deubiquitinating enzymes (DUBs) regulate antiviral immune response through targeting DNA sensor signaling pathway members. As one of the DNA sensors, interferon (IFN)-γ inducible protein 16 (IFI16) play a major role in response to virus infections through activating the canonical STING/TBK-1/IRF3 signaling pathway. Only a few studies discuss the function of DUBs in IFI16-mediated antiviral response. Ubiquitin-specific protease 12 (USP12), which is one of the major members of the USP family, participates in various biological functions. However, whether USP12 regulates the nucleic acid sensor to modulate antiviral immune responses has not yet been elucidated. In this study, we found that knockout or knockdown of USP12 impaired the HSV-1-induced expressions of IFN-β, CCL-5, IL-6, and downstream interferon-stimulated genes (ISGs). Moreover, USP12 deficiency increased HSV-1 replication and host susceptibility to HSV-1 infection. Mechanistically, USP12 inhibited the proteasome-dependent degradation of IFI16 through its deubiquitinase activity, thereby maintaining IFI16 stability and promoting IFI16-STING-IRF3- and p65-mediated antiviral signaling. Overall, our findings demonstrate an essential role of USP12 in DNA-sensing signaling and contribute to the understanding of deubiquitination-mediated regulation of innate antiviral responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Biotherapy, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, China.
- Department of Laboratory Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
- Institute of Molecular Immunology, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, China.
- The Second Affiliated Hospital, The State Key Laboratory of Respiratory Disease, Guangdong Provincial Key Laboratory of Allergy & Clinical Immunology, Guangzhou Medical University, Guangzhou, China.
- Department of Rheumatology and Clinical Immunology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
ORCID-Profile: Shengfeng Hu
Förderung
- National Natural Science Foundation of China
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Fu, Y., Zhan, X., You, X., Nie, D., Mai, H., Chen, Y., He, S., Sheng, J., Zeng, Z., Li, H., Li, J., & Hu, S. (2023). USP12 promotes antiviral responses by deubiquitinating and stabilizing IFI16. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1011480
Vancouver
Fu Y, Zhan X, You X, Nie D, Mai H, Chen Y, et al. USP12 promotes antiviral responses by deubiquitinating and stabilizing IFI16. PLOS Pathogens. 2023. doi:10.1371/journal.ppat.1011480
BibTeX
@article{Fu2023,
author = {Fu, Yuling and Zhan, Xiaoxia and You, Xiaolong and Nie, Dingnai and Mai, Haiyan and Chen, Yitian and He, Shitong and Sheng, Junli and Zeng, Zhijie and Li, Hongwei and Li, Jinlong and Hu, Shengfeng},
title = {USP12 promotes antiviral responses by deubiquitinating and stabilizing IFI16},
journal = {PLOS Pathogens},
year = {2023},
doi = {10.1371/journal.ppat.1011480}
}
EUVIMED